APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Spit Test Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cancer Spit Test Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026198 pages

Choose your research edition.

Industry ResearchCancer Spit Test Device Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Spit Test Device Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Cancer Spit Test Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Spit Test Device Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Spit Test Device Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Cancer Spit Test Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cancer Spit Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Spit Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Spit Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cancer Spit Test Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Spit Test Device include Thermo Fisher Scientific, Siemens Healthineers, Sarstedt, Salimetrics, Roche Holding AG, Qiagen, PeriRx, Oasis Diagnostics Corporation and Miraclean Technology Co.,Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cancer Spit Test Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Spit Test Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Spit Test Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cancer Spit Test Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Spit Test Device Segment by Company

Thermo Fisher Scientific

Siemens Healthineers

Sarstedt

Salimetrics

Roche Holding AG

Qiagen

PeriRx

Oasis Diagnostics Corporation

Miraclean Technology Co.,Ltd.

Illumina

DNA Genotek Inc.

Color Health Inc

Canvax

BioMerieux

Biocartis Group

BD

Agilent Technologies

Abbott Laboratories

Cancer Spit Test Device Segment by Type

Passive Drool Collection Methods

Oral Swab Collection Methods

Cancer Spit Test Device Segment by Application

Cancer Research Institutes

Hospitals

Diagnostic Laboratories

Oncology Speciality Clinics

Others

Cancer Spit Test Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Spit Test Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Spit Test Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Spit Test Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cancer Spit Test Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Spit Test Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cancer Spit Test Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cancer Spit Test Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cancer Spit Test Device Industry Trends Table 2. Cancer Spit Test Device Industry Drivers Table 3. Cancer Spit Test Device Industry Opportunities and Challenges Table 4. Cancer Spit Test Device Industry Restraints Table 5. Global Cancer Spit Test Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cancer Spit Test Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cancer Spit Test Device Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Cancer Spit Test Device Sales Market Share by Manufacturers Table 9. Global Cancer Spit Test Device Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Cancer Spit Test Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cancer Spit Test Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cancer Spit Test Device Manufacturers, Product Type & Application Table 13. Global Cancer Spit Test Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cancer Spit Test Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Passive Drool Collection Methods Table 17. Major Manufacturers of Oral Swab Collection Methods Table 18. Global Cancer Spit Test Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Cancer Spit Test Device Sales by Type (2021-2026) & (k units) Table 20. Global Cancer Spit Test Device Sales by Type (2027-2032) & (k units) Table 21. Global Cancer Spit Test Device Sales Market Share by Type (2021-2026) Table 22. Global Cancer Spit Test Device Sales Market Share by Type (2027-2032) Table 23. Global Cancer Spit Test Device Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Cancer Spit Test Device Revenue by Type (2021-2026) & (k units) Table 25. Global Cancer Spit Test Device Revenue by Type (2027-2032) & (k units) Table 26. Global Cancer Spit Test Device Revenue Market Share by Type (2021-2026) Table 27. Global Cancer Spit Test Device Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Cancer Research Institutes Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Diagnostic Laboratories Table 31. Major Manufacturers of Oncology Speciality Clinics Table 32. Major Manufacturers of Others Table 33. Global Cancer Spit Test Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Cancer Spit Test Device Sales by Application (2021-2026) & (k units) Table 35. Global Cancer Spit Test Device Sales by Application (2027-2032) & (k units) Table 36. Global Cancer Spit Test Device Sales Market Share by Application (2021-2026) Table 37. Global Cancer Spit Test Device Sales Market Share by Application (2027-2032) Table 38. Global Cancer Spit Test Device Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Cancer Spit Test Device Revenue by Application (2021-2026) & (k units) Table 40. Global Cancer Spit Test Device Revenue by Application (2027-2032) & (k units) Table 41. Global Cancer Spit Test Device Revenue Market Share by Application (2021-2026) Table 42. Global Cancer Spit Test Device Revenue Market Share by Application (2027-2032) Table 43. Global Cancer Spit Test Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Cancer Spit Test Device Sales by Region (2021-2026) & (k units) Table 45. Global Cancer Spit Test Device Sales Market Share by Region (2021-2026) Table 46. Global Cancer Spit Test Device Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Cancer Spit Test Device Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Cancer Spit Test Device Sales by Country (2021-2026) & (k units) Table 50. North America Cancer Spit Test Device Sales by Country (2027-2032) & (k units) Table 51. Europe Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Cancer Spit Test Device Sales by Country (2021-2026) & (k units) Table 53. Europe Cancer Spit Test Device Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Cancer Spit Test Device Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Cancer Spit Test Device Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Cancer Spit Test Device Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Cancer Spit Test Device Sales by Country (2027-2032) & (k units) Table 60. Global Cancer Spit Test Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Cancer Spit Test Device Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Cancer Spit Test Device Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Cancer Spit Test Device Revenue Market Share by Region (2021-2026) Table 64. Global Cancer Spit Test Device Revenue Market Share by Region (2027-2032) Table 65. Thermo Fisher Scientific Company Information Table 66. Thermo Fisher Scientific Business Overview Table 67. Thermo Fisher Scientific Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Thermo Fisher Scientific Cancer Spit Test Device Product Portfolio Table 69. Thermo Fisher Scientific Recent Development Table 70. Siemens Healthineers Company Information Table 71. Siemens Healthineers Business Overview Table 72. Siemens Healthineers Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Siemens Healthineers Cancer Spit Test Device Product Portfolio Table 74. Siemens Healthineers Recent Development Table 75. Sarstedt Company Information Table 76. Sarstedt Business Overview Table 77. Sarstedt Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sarstedt Cancer Spit Test Device Product Portfolio Table 79. Sarstedt Recent Development Table 80. Salimetrics Company Information Table 81. Salimetrics Business Overview Table 82. Salimetrics Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Salimetrics Cancer Spit Test Device Product Portfolio Table 84. Salimetrics Recent Development Table 85. Roche Holding AG Company Information Table 86. Roche Holding AG Business Overview Table 87. Roche Holding AG Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Roche Holding AG Cancer Spit Test Device Product Portfolio Table 89. Roche Holding AG Recent Development Table 90. Qiagen Company Information Table 91. Qiagen Business Overview Table 92. Qiagen Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Qiagen Cancer Spit Test Device Product Portfolio Table 94. Qiagen Recent Development Table 95. PeriRx Company Information Table 96. PeriRx Business Overview Table 97. PeriRx Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. PeriRx Cancer Spit Test Device Product Portfolio Table 99. PeriRx Recent Development Table 100. Oasis Diagnostics Corporation Company Information Table 101. Oasis Diagnostics Corporation Business Overview Table 102. Oasis Diagnostics Corporation Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Oasis Diagnostics Corporation Cancer Spit Test Device Product Portfolio Table 104. Oasis Diagnostics Corporation Recent Development Table 105. Miraclean Technology Co.,Ltd. Company Information Table 106. Miraclean Technology Co.,Ltd. Business Overview Table 107. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Miraclean Technology Co.,Ltd. Cancer Spit Test Device Product Portfolio Table 109. Miraclean Technology Co.,Ltd. Recent Development Table 110. Illumina Company Information Table 111. Illumina Business Overview Table 112. Illumina Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Illumina Cancer Spit Test Device Product Portfolio Table 114. Illumina Recent Development Table 115. DNA Genotek Inc. Company Information Table 116. DNA Genotek Inc. Business Overview Table 117. DNA Genotek Inc. Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. DNA Genotek Inc. Cancer Spit Test Device Product Portfolio Table 119. DNA Genotek Inc. Recent Development Table 120. Color Health Inc Company Information Table 121. Color Health Inc Business Overview Table 122. Color Health Inc Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Color Health Inc Cancer Spit Test Device Product Portfolio Table 124. Color Health Inc Recent Development Table 125. Canvax Company Information Table 126. Canvax Business Overview Table 127. Canvax Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Canvax Cancer Spit Test Device Product Portfolio Table 129. Canvax Recent Development Table 130. BioMerieux Company Information Table 131. BioMerieux Business Overview Table 132. BioMerieux Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. BioMerieux Cancer Spit Test Device Product Portfolio Table 134. BioMerieux Recent Development Table 135. Biocartis Group Company Information Table 136. Biocartis Group Business Overview Table 137. Biocartis Group Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Biocartis Group Cancer Spit Test Device Product Portfolio Table 139. Biocartis Group Recent Development Table 140. BD Company Information Table 141. BD Business Overview Table 142. BD Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. BD Cancer Spit Test Device Product Portfolio Table 144. BD Recent Development Table 145. Agilent Technologies Company Information Table 146. Agilent Technologies Business Overview Table 147. Agilent Technologies Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Agilent Technologies Cancer Spit Test Device Product Portfolio Table 149. Agilent Technologies Recent Development Table 150. Abbott Laboratories Company Information Table 151. Abbott Laboratories Business Overview Table 152. Abbott Laboratories Cancer Spit Test Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Abbott Laboratories Cancer Spit Test Device Product Portfolio Table 154. Abbott Laboratories Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Cancer Spit Test Device Distributors List Table 158. Cancer Spit Test Device Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Cancer Spit Test Device Product Image Figure 2. Global Cancer Spit Test Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Spit Test Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Spit Test Device Sales (2021-2032) & (k units) Figure 5. Global Cancer Spit Test Device Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cancer Spit Test Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Passive Drool Collection Methods Image Figure 9. Oral Swab Collection Methods Image Figure 10. Global Cancer Spit Test Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Cancer Spit Test Device Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cancer Spit Test Device Sales Market Share by Type (2021-2032) Figure 13. Global Cancer Spit Test Device Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Cancer Spit Test Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cancer Spit Test Device Revenue Market Share by Type (2021-2032) Figure 16. Cancer Research Institutes Image Figure 17. Hospitals Image Figure 18. Diagnostic Laboratories Image Figure 19. Oncology Speciality Clinics Image Figure 20. Others Image Figure 21. Global Cancer Spit Test Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Cancer Spit Test Device Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Cancer Spit Test Device Sales Market Share by Application (2021-2032) Figure 24. Global Cancer Spit Test Device Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Cancer Spit Test Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Cancer Spit Test Device Revenue Market Share by Application (2021-2032) Figure 27. North America Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Cancer Spit Test Device Sales Market Share by Country (2021-2032) Figure 29. U.S. Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Cancer Spit Test Device Sales Market Share by Country (2021-2032) Figure 34. Germany Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Cancer Spit Test Device Sales Market Share by Country (2021-2032) Figure 41. China Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Cancer Spit Test Device Sales Market Share by Country (2021-2032) Figure 49. Brazil Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Cancer Spit Test Device Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Cancer Spit Test Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Cancer Spit Test Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Cancer Spit Test Device Revenue (2021-2032) & (US$ Million) Figure 60. North America Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Cancer Spit Test Device Revenue (2021-2032) & (US$ Million) Figure 62. Europe Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Cancer Spit Test Device Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Cancer Spit Test Device Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Cancer Spit Test Device Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Cancer Spit Test Device Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Passive Drool Collection Methods
  • Oral Swab Collection Methods
Applications
  • Cancer Research Institutes
  • Hospitals
  • Diagnostic Laboratories
  • Oncology Speciality Clinics
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Sarstedt
  • Salimetrics
  • Roche Holding AG
  • Qiagen
  • PeriRx
  • Oasis Diagnostics Corporation
  • Miraclean Technology Co.,Ltd.
  • Illumina
  • DNA Genotek Inc.
  • Color Health Inc
  • Canvax
  • BioMerieux
  • Biocartis Group
  • BD
  • Agilent Technologies
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cancer Spit Test Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cancer Spit Test Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cancer Spit Test Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cancer Spit Test Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cancer Spit Test Device Market Dynamics
  1. 2.1 Cancer Spit Test Device Industry Trends
  2. 2.2 Cancer Spit Test Device Industry Drivers
  3. 2.3 Cancer Spit Test Device Industry Opportunities and Challenges
  4. 2.4 Cancer Spit Test Device Industry Restraints
3 Cancer Spit Test Device Market by Manufacturers
  1. 3.1 Global Cancer Spit Test Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cancer Spit Test Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cancer Spit Test Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cancer Spit Test Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Spit Test Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cancer Spit Test Device Manufacturers, Product Type & Application
  7. 3.7 Global Cancer Spit Test Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Spit Test Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Spit Test Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Spit Test Device Tier 1, Tier 2, and Tier 3
4 Cancer Spit Test Device Market by Type
  1. 4.1 Cancer Spit Test Device Type Introduction
  2. 4.1.1 Passive Drool Collection Methods
  3. 4.1.2 Oral Swab Collection Methods
  4. 4.2 Global Cancer Spit Test Device Sales by Type
  5. 4.2.1 Global Cancer Spit Test Device Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cancer Spit Test Device Sales by Type (2021-2032)
  7. 4.2.3 Global Cancer Spit Test Device Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cancer Spit Test Device Revenue by Type
  9. 4.3.1 Global Cancer Spit Test Device Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cancer Spit Test Device Revenue by Type (2021-2032)
  11. 4.3.3 Global Cancer Spit Test Device Revenue Market Share by Type (2021-2032)
5 Cancer Spit Test Device Market by Application
  1. 5.1 Cancer Spit Test Device Application Introduction
  2. 5.1.1 Cancer Research Institutes
  3. 5.1.2 Hospitals
  4. 5.1.3 Diagnostic Laboratories
  5. 5.1.4 Oncology Speciality Clinics
  6. 5.1.5 Others
  7. 5.2 Global Cancer Spit Test Device Sales by Application
  8. 5.2.1 Global Cancer Spit Test Device Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Cancer Spit Test Device Sales by Application (2021-2032)
  10. 5.2.3 Global Cancer Spit Test Device Sales Market Share by Application (2021-2032)
  11. 5.3 Global Cancer Spit Test Device Revenue by Application
  12. 5.3.1 Global Cancer Spit Test Device Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Cancer Spit Test Device Revenue by Application (2021-2032)
  14. 5.3.3 Global Cancer Spit Test Device Revenue Market Share by Application (2021-2032)
6 Global Cancer Spit Test Device Sales by Region
  1. 6.1 Global Cancer Spit Test Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cancer Spit Test Device Sales by Region (2021-2032)
  3. 6.2.1 Global Cancer Spit Test Device Sales by Region (2021-2026)
  4. 6.2.2 Global Cancer Spit Test Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cancer Spit Test Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cancer Spit Test Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cancer Spit Test Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cancer Spit Test Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cancer Spit Test Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cancer Spit Test Device Revenue by Region
  1. 7.1 Global Cancer Spit Test Device Revenue by Region
  2. 7.1.1 Global Cancer Spit Test Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cancer Spit Test Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Cancer Spit Test Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Cancer Spit Test Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cancer Spit Test Device Revenue (2021-2032)
  8. 7.2.2 North America Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cancer Spit Test Device Revenue (2021-2032)
  11. 7.3.2 Europe Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cancer Spit Test Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cancer Spit Test Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cancer Spit Test Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Cancer Spit Test Device Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Siemens Healthineers
  8. 8.2.1 Siemens Healthineers Company Information
  9. 8.2.2 Siemens Healthineers Business Overview
  10. 8.2.3 Siemens Healthineers Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthineers Cancer Spit Test Device Product Portfolio
  12. 8.2.5 Siemens Healthineers Recent Developments
  13. 8.3 Sarstedt
  14. 8.3.1 Sarstedt Company Information
  15. 8.3.2 Sarstedt Business Overview
  16. 8.3.3 Sarstedt Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sarstedt Cancer Spit Test Device Product Portfolio
  18. 8.3.5 Sarstedt Recent Developments
  19. 8.4 Salimetrics
  20. 8.4.1 Salimetrics Company Information
  21. 8.4.2 Salimetrics Business Overview
  22. 8.4.3 Salimetrics Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Salimetrics Cancer Spit Test Device Product Portfolio
  24. 8.4.5 Salimetrics Recent Developments
  25. 8.5 Roche Holding AG
  26. 8.5.1 Roche Holding AG Company Information
  27. 8.5.2 Roche Holding AG Business Overview
  28. 8.5.3 Roche Holding AG Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Holding AG Cancer Spit Test Device Product Portfolio
  30. 8.5.5 Roche Holding AG Recent Developments
  31. 8.6 Qiagen
  32. 8.6.1 Qiagen Company Information
  33. 8.6.2 Qiagen Business Overview
  34. 8.6.3 Qiagen Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Qiagen Cancer Spit Test Device Product Portfolio
  36. 8.6.5 Qiagen Recent Developments
  37. 8.7 PeriRx
  38. 8.7.1 PeriRx Company Information
  39. 8.7.2 PeriRx Business Overview
  40. 8.7.3 PeriRx Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PeriRx Cancer Spit Test Device Product Portfolio
  42. 8.7.5 PeriRx Recent Developments
  43. 8.8 Oasis Diagnostics Corporation
  44. 8.8.1 Oasis Diagnostics Corporation Company Information
  45. 8.8.2 Oasis Diagnostics Corporation Business Overview
  46. 8.8.3 Oasis Diagnostics Corporation Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Oasis Diagnostics Corporation Cancer Spit Test Device Product Portfolio
  48. 8.8.5 Oasis Diagnostics Corporation Recent Developments
  49. 8.9 Miraclean Technology Co.,Ltd.
  50. 8.9.1 Miraclean Technology Co.,Ltd. Company Information
  51. 8.9.2 Miraclean Technology Co.,Ltd. Business Overview
  52. 8.9.3 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Miraclean Technology Co.,Ltd. Cancer Spit Test Device Product Portfolio
  54. 8.9.5 Miraclean Technology Co.,Ltd. Recent Developments
  55. 8.10 Illumina
  56. 8.10.1 Illumina Company Information
  57. 8.10.2 Illumina Business Overview
  58. 8.10.3 Illumina Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Illumina Cancer Spit Test Device Product Portfolio
  60. 8.10.5 Illumina Recent Developments
  61. 8.11 DNA Genotek Inc.
  62. 8.11.1 DNA Genotek Inc. Company Information
  63. 8.11.2 DNA Genotek Inc. Business Overview
  64. 8.11.3 DNA Genotek Inc. Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DNA Genotek Inc. Cancer Spit Test Device Product Portfolio
  66. 8.11.5 DNA Genotek Inc. Recent Developments
  67. 8.12 Color Health Inc
  68. 8.12.1 Color Health Inc Company Information
  69. 8.12.2 Color Health Inc Business Overview
  70. 8.12.3 Color Health Inc Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Color Health Inc Cancer Spit Test Device Product Portfolio
  72. 8.12.5 Color Health Inc Recent Developments
  73. 8.13 Canvax
  74. 8.13.1 Canvax Company Information
  75. 8.13.2 Canvax Business Overview
  76. 8.13.3 Canvax Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Canvax Cancer Spit Test Device Product Portfolio
  78. 8.13.5 Canvax Recent Developments
  79. 8.14 BioMerieux
  80. 8.14.1 BioMerieux Company Information
  81. 8.14.2 BioMerieux Business Overview
  82. 8.14.3 BioMerieux Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BioMerieux Cancer Spit Test Device Product Portfolio
  84. 8.14.5 BioMerieux Recent Developments
  85. 8.15 Biocartis Group
  86. 8.15.1 Biocartis Group Company Information
  87. 8.15.2 Biocartis Group Business Overview
  88. 8.15.3 Biocartis Group Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Biocartis Group Cancer Spit Test Device Product Portfolio
  90. 8.15.5 Biocartis Group Recent Developments
  91. 8.16 BD
  92. 8.16.1 BD Company Information
  93. 8.16.2 BD Business Overview
  94. 8.16.3 BD Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BD Cancer Spit Test Device Product Portfolio
  96. 8.16.5 BD Recent Developments
  97. 8.17 Agilent Technologies
  98. 8.17.1 Agilent Technologies Company Information
  99. 8.17.2 Agilent Technologies Business Overview
  100. 8.17.3 Agilent Technologies Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Agilent Technologies Cancer Spit Test Device Product Portfolio
  102. 8.17.5 Agilent Technologies Recent Developments
  103. 8.18 Abbott Laboratories
  104. 8.18.1 Abbott Laboratories Company Information
  105. 8.18.2 Abbott Laboratories Business Overview
  106. 8.18.3 Abbott Laboratories Cancer Spit Test Device Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Abbott Laboratories Cancer Spit Test Device Product Portfolio
  108. 8.18.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cancer Spit Test Device Value Chain Analysis
  2. 9.1.1 Cancer Spit Test Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cancer Spit Test Device Production Mode & Process
  6. 9.2 Cancer Spit Test Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cancer Spit Test Device Distributors
  9. 9.2.3 Cancer Spit Test Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst